Kidney cancer patients shocked by NICE decision

Thousands of kidney cancer patients are devastated after plans to ban life-extending new drugs.

Four drugs which can offer patients extra years with their loved ones have been rejected by the Government's rationing body because they cost too much.

The National Institute for Health and Clinical Excellence admits the drugs work, but says that if they are approved, patients with other diseases will have to go without.

The clinical negligence team at Bond Pearce LLP are currently assisting a patient who is appealing a decision by his Primary Care Trust to fund treatment recommended by the patients Consultant.

If you would like to seek expert legal advice relating to this case study or any other injury claim please complete the online enquiry form or call 0800 915 4650

This news section contains information of interest to our visitors from publicly available sources. Where we are linked to a story or are representing the person"s referred to we will say so. Where we do not represent individuals or bodies mentioned or quoted, the inclusion of the news story in our news section is not intended nor should it be taken to imply that we act for the individual or body concerned.